Worldwide, cryptococcal meningitis kills up to 180,000 persons annually and is the most common cause of nonviral meningitis in the United States. Besides patients with immunosuppression due to human ...

Introduction Cryptococcal meningitis (CM) is an infection of the central nervous system that accounts for approximately 19% ...

Cryptococcal meningitis is the second-biggest killer of people living with HIV after tuberculosis. Now, a global initiative aims to get the gold-standard drug to treat cryptococcal meningitis, ...

Find effective medications for 'Cryptococcal Meningitis treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed to ...

A: An internist or infectious diseases specialist will treat cryptococcal meningitis. A: Cryptococcal paradoxical IRIS (immune reconstitution inflammatory syndrome) is a complication that arises after ...

A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, new University of Liverpool research warns.

Dar es Salaam / Lilongwe / Geneva — 15 April 2025 — A new, easier-to-administer and patient-friendly sustained-release formulation of flucytosine, a medicine used to treat cryptococcal meningitis, has ...

Future Microbiology. 2010;5(8):1269-1288. Another crucial link in anti-cryptococcal host defense is the mononuclear phagocyte (macrophages and monocytes). These leukocytes direct the outcome of the ...

Amphotericin B iv. 0.7–1 mg/kg q.d., plus flucytosine o.s. 25 mg/kg q.i.d. Fluconazole o.s./iv. 800–1200 mg q.d. Fluconazole o.s./iv. 400 mg q.d. Fluconazole o.s ...

A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, new University of Liverpool research warns.

A new, easier-to-administer and patient-friendly sustained-release formulation of flucytosine, a medicine used to treat cryptococcal meningitis, has entered Phase II clinical trials in Malawi and ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...